Andrea Palermo, MD (he/him/his)

Professor
Fondazione Policlinico Universitario Campus Bio-Medico
Rome, Italy

Disclosure information not submitted.

Presentation(s):

• ORF16-04 - Encaleret Restores Mineral Homeostasis in Autosomal Dominant Hypocalcemia Type 1 (ADH1): Primary Results from the Phase 3 CALIBRATE Trial

  Saturday, June 13, 2026
  2:00 PM - 2:15 PM CT

• ORF16-07 - Palopegteriparatide Treatment in Adults with Hypoparathyroidism: Final Results of the Phase 3 PaTHway Trial

  Saturday, June 13, 2026
  2:45 PM - 3:00 PM CT

• SUN-829 - Anthropometric Indices and Markers of Atherothrombotic Risk in Subjects with Primary Hyperpathyroidism.

  Sunday, June 14, 2026
  9:00 AM - 4:00 PM CT

• MON-771 - Improvements in Patient-Reported Outcomes With Eneboparatide in Chronic Hypoparathyroidism Over 1 Year: A Phase 3, Randomized, Placebo-Controlled and Open-Label Study Assessing the Efficacy and Safety of Eneboparatide (CALYPSO)

  Monday, June 15, 2026
  9:00 AM - 2:00 PM CT

• MON-850 - Chronic PTH Elevation Fails to Induce Significant Adipose Tissue Remodeling in Primary Hyperparathyroidism

  Monday, June 15, 2026
  9:00 AM - 2:00 PM CT